Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. Isomorphic Labs ...

Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI model that was developed by Isomorphic Labs and Google DeepMind. According to ...

Josh Kushner's Thrive Capital and Alphabet GOOG are leading new financing for Isomorphic Labs, an AI-powered drug discovery ...

Alphabet's Isomorphic Labs has raised more than $2bn in funds to accelerate AI-powered drug discovery and tech expansion.

Alphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by ...

Isomorphic Labs secures $2.1 billion in funding to accelerate its AI-powered drug discovery engine and scale pharmaceutical ...

Isomorphic Labs secures $2.1 billion to advance AI-designed drug development, partnering with major pharmaceutical companies ...

Sir Demis Hassabis has hailed a multi-billion-dollar investment in the startup he founded which was spun out of Google ...

In 2024, DeepMind and Isomorphic Labs released a significantly improved successor to the model. AlphaFold 3 delivers a more ...

The proceeds will be used to accelerate Isomorphic Labs’ pipeline of therapeutic programmes and further develop its IsoDDE AI drug design engine.